首页> 美国卫生研究院文献>Biophysical Journal >A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.
【2h】

A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.

机译:一种物理化学方法用于预测基于质粒的基因治疗中基于肽的基因递送系统的有效性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel synthetic peptides, based on carrier peptide analogs (YKAKnWK) and an amphipathic peptide (GLFEALLELLESLWELLLEA), have been formulated with DNA plasmids to create peptide-based gene delivery systems. The carrier peptides are used to condense plasmids into nanoparticles with a hydrodynamic diameter (DH) ranging from 40 to 200 nm, which are sterically stable for over 100 h. Size and morphology of the carrier peptide/plasmid complex have been determined by photon correlation spectroscopy (PCS) and transmission electron microscopy (TEM), respectively. The amphipathic peptide is used as a pH-sensitive lytic agent to facilitate release of the plasmid from endosomes after endocytosis of the peptide/plasmid complex. Hemolysis assays have shown that the amphipathic peptide destabilizes lipid bilayers at low pH, mimicking the properties of viral fusogenic peptides. However, circular dichroism studies show that unlike the viral fusion peptides, this amphipathic peptide loses some of its alpha-helical structure at low pH in the presence of liposomes. The peptide-based gene delivery systems were tested for transfection efficiency in a variety of cell lines, including 14-day C2C12 mouse myotubes, using gene expression systems containing the beta-galactosidase reporter gene. Transfection data demonstrate a correlation between in vitro transfection efficiency and the combination of several physical properties of the peptide/plasmid complexes, including 1) DNA dose, 2) the zeta potential of the particle, 3) the requirement of both lytic and carrier peptides, and 4) the number of lysine residues associated with the carrier peptide. Transfection data on 14-day C2C12 myotubes utilizing the therapeutic human growth hormone gene formulated in an optimal peptide gene delivery system show an increase in gene expression over time, with a maximum in protein levels at 96 h (approximately 18 ng/ml).
机译:已基于DNA质粒配制了基于载体肽类似物(YKAKnWK)和两亲性肽(GLFEALLELLESLWELLLEA)的新型合成肽,以创建基于肽的基因递送系统。载体肽用于将质粒浓缩为流体动力学直径(DH)为40至200 nm的纳米颗粒,其在空间上稳定100多个小时。载体肽/质粒复合物的大小和形态分别通过光子相关光谱法(PCS)和透射电子显微镜(TEM)确定。两亲性肽用作pH敏感的溶解剂,以促进在肽/质粒复合物内吞后质粒从内体释放。溶血分析表明,两亲性肽在低pH值时会破坏脂质双层的稳定性,模仿了病毒融合肽的特性。但是,圆二色性研究表明,与病毒融合肽不同,这种两亲性肽在脂质体存在下在低pH值下会失去一些其α螺旋结构。使用包含β-半乳糖苷酶报道基因的基因表达系统,测试了基于肽的基因传递系统在包括14天C2C12小鼠肌管在内的多种细胞系中的转染效率。转染数据证明了体外转染效率与肽/质粒复合物的几种物理性质的组合之间的相关性,包括1)DNA剂量,2)颗粒的ζ电势,3)裂解肽和载体肽的需求, 4)与载体肽相关的赖氨酸残基的数目。利用在最佳肽基因递送系统中配制的治疗性人类生长激素基因进行的14天C2C12肌管的转染数据显示,基因表达随时间增加,在96 h时蛋白质含量最高(约18 ng / ml)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号